We serve Chemical Name:1-benzyl-4-hydroxy-1,8-naphthyridin-2-one CAS:219775-95-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-benzyl-4-hydroxy-1,8-naphthyridin-2-one
CAS.NO:219775-95-8
Synonyms:1-benzyl-4-hydroxy-1,8-naphthyridin-2-one
Molecular Formula:C15H12N2O2
Molecular Weight:252.26800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.12000
Exact Mass:252.09000
LogP:2.15040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-benzyl-4-hydroxy-1,8-naphthyridin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-4-hydroxy-1,8-naphthyridin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-4-hydroxy-1,8-naphthyridin-2-one Use and application,1-benzyl-4-hydroxy-1,8-naphthyridin-2-one technical grade,usp/ep/jp grade.
Related News: In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. 1-benzyl-4-hydroxy-1,8-naphthyridin-2-one manufacturer As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak. 1-benzyl-4-hydroxy-1,8-naphthyridin-2-one supplier As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak. 1-benzyl-4-hydroxy-1,8-naphthyridin-2-one vendor The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 1-benzyl-4-hydroxy-1,8-naphthyridin-2-one factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.
